Aliso Viejo, CA – Ambry Genetics, a global leader in clinical diagnostics and genomic services, announced today that they have officially reached a new milestone in Next-Gen sequencing. “We have reached an incredible milestone in next-generation sequencing (NGS),” said Ardy Arianpour, Vice President of Business Development at Ambry Genetics.” Ever since NGS was launched, we […]
Dako, an Agilent Technologies Company and worldwide provider of cancer diagnostics, announced today it has received approval from the U.S. Food and Drug Administration for the addition of Kadcyla in the labeling of two Dako companion diagnostic assays. Kadcyla (ado-trastuzumab emtansine) is Genentech’s new medicine for patients with HER2-positive metastatic breast cancer who have received […]
SAN DIEGO, CA –- Trovagene, Inc. (NASDAQ: TROV), a developer of transrenal molecular diagnostics, today announced that Mark Erlander, Ph.D., has joined the company as chief scientific officer. Dr. Erlander has more than 18 years of experience directing research teams with a strong focus in oncology-based molecular diagnostics. He has developed multiple novel molecular diagnostic […]
GLOSTRUP, Denmark, – Dako, an Agilent Technologies Company and worldwide provider of cancer diagnostics, unveiled the newest addition to its IHC portfolio at the 2013 USCAP congress in Baltimore, Maryland, today. As the exclusive Platinum Sponsor of the congress, Dako used the opportunity to present its new advanced staining solution to a global gathering of […]
CAMBRIDGE, Mass., – Foundation Medicine, Inc. today announced that it has received accreditation from the Commission on Laboratory Accreditation of the College of American Pathologists (CAP) based on the results of a recent on-site laboratory inspection. The U.S. federal government recognizes the CAP Laboratory Accreditation Program as being equal-to or more-stringent-than the government’s own inspection […]
Agilent Technologies Introduces CE-IVD Marked SureScan Dx Microarray Scanner for the European Market
Agilent Technologies Inc. (NYSE: A) today launched new SureScan Dx microarray scanner that is CE marked for in vitro diagnostic use in Europe. The SureScan Dx microarray scanner is indicated for use in a clinical laboratory environment when measuring fluorescence signals of labeled DNA or RNA targets hybridized to microarrays used as part of a […]
ELMWOOD PARK, N.J., — Bio-Reference Laboratories, Inc. (Nasdaq:BRLI) announced today that the Company and Natera have entered into a definitive agreement to commercialize the Panorama™ non-invasive prenatal screening test developed by Natera. The Panorama test will be sold by the GenPath business unit of Bioreference. Panorama is a simple blood test that uses cutting-edge genotyping […]
Munich, Germany, – Definiens, the global leader of image and data analysis solutions for quantitative digital pathology, today announced the appointment of renowned surgical and anatomical pathologist Dr. Ralf Huss as Chief Medical Officer (CMO). Professor Huss brings significant expertise in pathology and will play a key role in expanding Definiens’ leading position in image […]
Biocartis will use this IWT-subsidy (from the Flemish government) to develop new diagnostic cancer tests that will facilitate more targeted treatment and improve survival rates for patients. Biocartis is a molecular diagnostics company that develops clinically relevant tests and innovative, easy-to-use platforms to be employed, amongst other indications, in the fight against cancer. With this […]
Both the Radiometer and HemoCue companies are leading in their respective fields of point-of-care, or near-patient testing. The transaction is expected to be completed in March 2013, subject to customary closing conditions. Assuming the acquisition’s completion, Radiometer and HemoCue will continue operations as separate companies and brands. This acquisition will enable both HemoCue and Radiometer […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
